论文部分内容阅读
目的探究硫酸镁联合复方异丙托溴铵雾化吸入治疗小儿哮喘的效果。方法资料随机选取2013年5月~2014年5月本院收治的95例哮喘患儿,随机分为研究组48例,对照组47例。对照组行复方异丙托溴铵雾化吸入治疗,研究组行硫酸镁联合复方异丙托溴铵雾化吸入治疗,分析两组疗效。结果治疗后研究组FEV1、FEV1%水平均大于对照组;研究组各症状消失时间均少于对照组差异有统计学意义(P<0.05)。结论硫酸镁联合复方异丙托溴铵雾化吸入治疗小儿哮喘可有效改善患儿肺功能,缩短症状缓解时间。
Objective To investigate the effect of magnesium sulfate combined with ipratropium bromide in the treatment of pediatric asthma. METHODS: A total of 95 asthmatic children admitted to our hospital from May 2013 to May 2014 were randomly divided into study group (48 cases) and control group (47 cases). The control group received ipratropium bromide inhalation therapy. The study group received magnesium sulfate combined with ipratropium bromide inhalation therapy. The curative effect of the two groups was analyzed. Results After treatment, the levels of FEV1 and FEV1% in the study group were greater than those in the control group. There was no significant difference in the disappearance time of symptoms between the two groups (P <0.05). Conclusion Magnesium sulfate combined with ipratropium bromide inhalation treatment of pediatric asthma can effectively improve children’s lung function and shorten the time of symptom relief.